HIV-1 antibody neutralization breadth is associated with enhanced HIV-specific CD4+ T cell responses

Journal of Virology

Volumn 90, Issue 5, 2016, Pages 2208-2220

  Ranasinghe, Srinika ^a,b   Soghoian, Damien Z ^a   Lindqvist, Madelene ^a   Ghebremichael, Musie ^a   Donaghey, Faith ^a   Carrington, Mary ^a,c   Seaman, Michael S ^d   Kaufmann, Daniel E ^a,b,e   Walker, Bruce D ^a,b,f   Porichis, Filippos ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAG PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HLA ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY; GP41 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IMMUNE RESPONSE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS STRAIN; BLOOD; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; VIROLOGY;

ADULT; ANTIBODIES, NEUTRALIZING; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED;

EID: 84961137842     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02278-15     Document Type: Article

References (42)

1. Burton DR, Mascola JR. 2015. Antibody responses to envelope glycoproteins in HIV-1 infection. Nat Immunol 16:571-576. http://dx.doi.org/10.1038/ni.3158.
2. Walker LM, Huber M, Doores KJ, Falkowska E, Pejchal R, Julien JP, Wang SK, Ramos A, Chan-Hui PY, Moyle M, Mitcham JL, Hammond PW, Olsen OA, Phung P, Fling S, Wong CH, Phogat S, Wrin T, Simek MD, Protocol GPI, Koff WC, Wilson IA, Burton DR, Poignard P. 2011. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477:466-470. http://dx.doi.org/10.1038/nature10373.
3. Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL, Wrin T, Simek MD, Fling S, Mitcham JL, Lehrman JK, Priddy FH, Olsen OA, Frey SM, Hammond PW, Protocol GPI, Kaminsky S, Zamb T, Moyle M, Koff WC, Poignard P, Burton DR. 2009. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326:285-289. http://dx.doi.org/10.1126/science.1178746.
4. Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, Oliveira TY, Pietzsch J, Fenyo D, Abadir A, Velinzon K, Hurley A, Myung S, Boulad F, Poignard P, Burton DR, Pereyra F, Ho DD, Walker BD, Seaman MS, Bjorkman PJ, Chait BT, Nussenzweig MC. 2011. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333:1633-1637. http://dx.doi.org/10.1126/science.1207227.
5. Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, Chen X, Longo NS, Louder M, McKee K, O'Dell S, Perfetto S, Schmidt SD, Shi W, Wu L, Yang Y, Yang ZY, Yang Z, Zhang Z, Bonsignori M, Crump JA, Kapiga SH, Sam NE, Haynes BF, Simek M, Burton DR, Koff WC, Doria-Rose NA, Connors M, Program NCS, Mullikin JC, Nabel GJ, Roederer M, Shapiro L, Kwong PD, Mascola JR. 2011. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333:1593-1602. http://dx.doi.org/10.1126/science.1207532.
6. Yamamoto T, Lynch RM, Gautam R, Matus-Nicodemos R, Schmidt SD, Boswell KL, Darko S, Wong P, Sheng Z, Petrovas C, McDermott AB, Seder RA, Keele BF, Shapiro L, Douek DC, Nishimura Y, Mascola JR, Martin MA, Koup RA. 2015. Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection. Sci Transl Med 7:298ra120. http://dx.doi.org/10.1126/scitranslmed.aab3964.
7. + memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39:758-769. http://dx.doi.org/10.1016/j.immuni.2013.08.031.
8. Boswell KL, Paris R, Boritz E, Ambrozak D, Yamamoto T, Darko S, Wloka K, Wheatley A, Narpala S, McDermott A, Roederer M, Haubrich R, Connors M, Ake J, Douek DC, Kim J, Petrovas C, Koup RA. 2014. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog 10:e1003853. http://dx.doi.org/10.1371/journal.ppat.1003853.
9. + helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection. J Virol 88: 13310-13321. http://dx.doi.org/10.1128/JVI.02186-14.
10. Harari A, Petitpierre S, Vallelian F, Pantaleo G. 2004. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103:966-972.
11. + T cells endowed with proliferative capacity. J Exp Med 198:1909-1922. http://dx.doi.org/10.1084/jem.20031598.
12. +T cell epitopes in chronic untreated clade C HIV-1 infection. PLoS One 4:e5013. http://dx.doi.org/10.1371/journal.pone.0005013.
13. Kaufmann DE, Bailey PM, Sidney J, Wagner B, Norris PJ, Johnston MN, Cosimi LA, Addo MM, Lichterfeld M, Altfeld M, Frahm N, Brander C, Sette A, Walker BD, Rosenberg ES. 2004. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol 78:4463-4477. http://dx.doi.org/10.1128/JVI.78.9.4463-4477.2004.
14. + T cell responses with HIV immune control. Nat Med 19:930-933. http://dx.doi.org/10.1038/nm.3229.
15. Ranasinghe S, Flanders M, Cutler S, Soghoian DZ, Ghebremichael M, Davis I, Lindqvist M, Pereyra F, Walker BD, Heckerman D, Streeck H. 2012. HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome. J Virol 86: 277-283. http://dx.doi.org/10.1128/JVI.05577-11.
16. Schieffer M, Jessen HK, Oster AF, Pissani F, Soghoian DZ, Lu R, Jessen AB, Zedlack C, Schultz BT, Davis I, Ranasinghe S, Rosenberg ES, Alter G, Schumann RR, Streeck H. 2014. Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control. J Virol 88:7357-7366. http://dx.doi.org/10.1128/JVI.00728-14.
17. Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, Ranasinghe S, Lindqvist M, Davis I, Lane K, Rychert J, Rosenberg ES, Piechocka-Trocha A, Brass AL, Brenchley JM, Walker BD, Streeck H. 2012. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med 4:123ra125. http://dx.doi.org/10.1126/scitranslmed.3003165.
18. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 5:518-525. http://dx.doi.org/10.1038/8400.
19. + T cell responses associated with control of viremia. Science 278:1447-1450. http://dx.doi.org/10.1126/science.278.5342.1447.
20. Porichis F, Kaufmann DE. 2011. HIV-specific CD4 T cells and immune control of viral replication. Curr Opin HIV AIDS 6:174-180. http://dx.doi.org/10.1097/COH.0b013e3283454058.
21. Streeck H, D'Souza MP, Littman DR, Crotty S. 2013. Harnessing CD4+ T cell responses in HIV vaccine development. Nat Med 19:143-149. http://dx.doi.org/10.1038/nm.3054.
22. Petrovas C, Koup RA. 2014. T follicular helper cells and HIV/SIV-specific antibody responses. Curr Opin HIV AIDS 9:235-241. http://dx.doi.org/10.1097/COH.0000000000000053.
23. Burton DR, Ahmed R, Barouch DH, Butera ST, Crotty S, Godzik A, Kaufmann DE, McElrath MJ, Nussenzweig MC, Pulendran B, Scanlan CN, Schief WR, Silvestri G, Streeck H, Walker BD, Walker LM, Ward AB, Wilson IA, Wyatt R. 2012. A blueprint for HIV vaccine discovery. Cell Host Microbe 12:396-407. http://dx.doi.org/10.1016/j.chom.2012.09.008.
24. Lewis GK, DeVico AL, Gallo RC. 2014. Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development. Proc Natl Acad Sci U S A 111:15614-15621. http://dx.doi.org/10.1073/pnas.1413550111.
25. Sarzotti-Kelsoe M, Bailer RT, Turk E, Lin CL, Bilska M, Greene KM, Gao H, Todd CA, Ozaki DA, Seaman MS, Mascola JR, Montefiori DC. 2014. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. J Immunol Methods 409:131-146. http://dx.doi.org/10.1016/j.jim.2013.11.022.
26. Martin-Gayo E, Buzon MJ, Ouyang Z, Hickman T, Cronin J, Pimenova D, Walker BD, Lichterfeld M, Yu XG. 2015. Potent cell-intrinsic immune responses in dendritic cells facilitate HIV-1-specific T cell immunity in HIV-1 elite controllers. PLoS Pathog 11:e1004930. http://dx.doi.org/10.1371/journal.ppat.1004930.
27. Huang J, Ofek G, Laub L, Louder MK, Doria-Rose NA, Longo NS, Imamichi H, Bailer RT, Chakrabarti B, Sharma SK, Alam SM, Wang T, Yang Y, Zhang B, Migueles SA, Wyatt R, Haynes BF, Kwong PD, Mascola JR, Connors M. 2012. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 491:406-412. http://dx.doi.org/10.1038/nature11544.
28. Sette A, Moutaftsi M, Moyron-Quiroz J, McCausland MM, Davies DH, Johnston RJ, Peters B, Rafii-El-Idrissi Benhnia M, Hoffmann J, Su HP, Singh K, Garboczi DN, Head S, Grey H, Felgner PL, Crotty S. 2008. Selective CD4 T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 28:847-858. http://dx.doi.org/10.1016/j.immuni.2008.04.018.
29. Lake P, Mitchison NA. 1976. Associative control of the immune response to cell surface antigens. Immunol Commun 5:795-805.
30. Russell SM, Liew FY. 1979. T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin. Nature 280:147-148. http://dx.doi.org/10.1038/280147a0.
31. Scherle PA, Gerhard W. 1986. Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J Exp Med 164:1114-1128.
32. Milich DR, McLachlan A, Thornton GB, Hughes JL. 1987. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329:547-549. http://dx.doi.org/10.1038/329547a0.
33. Yin L, Calvo-Calle JM, Cruz J, Newman FK, Frey SE, Ennis FA, Stern LJ. 2013. CD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humans. J Immunol 190: 6023-6033. http://dx.doi.org/10.4049/jimmunol.1202523.
34. Casimiro DR, Wang F, Schleif WA, Liang X, Zhang ZQ, Tobery TW, Davies ME, McDermott AB, O'Connor DH, Fridman A, Bagchi A, Tussey LG, Bett AJ, Finnefrock AC, Fu TM, Tang A, Wilson KA, Chen M, Perry HC, Heidecker GJ, Freed DC, Carella A, Punt KS, Sykes KJ, Huang L, Ausensi VI, Bachinsky M, Sadasivan-Nair U, Watkins DI, Emini EA, Shiver JW. 2005. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag. J Virol 79:15547-15555. http://dx.doi.org/10.1128/JVI.79.24.15547-15555.2005.
35. Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW. 2005. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. J Virol 79:12321-12331. http://dx.doi.org/10.1128/JVI.79.19.12321-12331.2005.
36. Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, Riggs AM, Abbink P, Coffey RT, Grandpre LE, Seaman MS, Landucci G, Forthal DN, Montefiori DC, Carville A, Mansfield KG, Havenga MJ, Pau MG, Goudsmit J, Barouch DH. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457:87-91. http://dx.doi.org/10.1038/nature07469.
37. + T-cells increase the antibody response to Env by intrastructural help. Retrovirology 10:117. http://dx.doi.org/10.1186/1742-4690-10-117.
38. Sette A, Buus S, Appella E, Adorini L, Grey HM. 1990. Structural requirements for the interaction between class II MHC molecules and peptide antigens. Immunol Res 9:2-7. http://dx.doi.org/10.1007/BF02918474.
39. Crotty S. 2015. A brief history of T cell help to B cells. Nat Rev Immunol 15:185-189. http://dx.doi.org/10.1038/nri3803.
40. Swain SL, McKinstry KK, Strutt TM. 2012. Expanding roles for CD4+ T cells in immunity to viruses. Nat Rev Immunol 12:136-148. http://dx.doi.org/10.1038/nri3152.
41. Lindqvist M, van Lunzen J, Soghoian DZ, Kuhl BD, Ranasinghe S, Kranias G, Flanders MD, Cutler S, Yudanin N, Muller MI, Davis I, Farber D, Hartjen P, Haag F, Alter G, Schulze zur Wiesch J, Streeck H. 2012. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 122:3271-3280. http://dx.doi.org/10.1172/JCI64314.
42. Storcksdieck Genannt Bonsmann M, Niezold T, Temchura V, Pissani F, Ehrhardt K, Brown EP, Osei-Owusu NY, Hannaman D, Hengel H, Ackerman ME, Streeck H, Nabi G, Tenbusch M, überla K. 2015. Enhancing the quality of antibodies to HIV-1 envelope by GagPol-specific Th cells. J Immunol 195:4861-4872. http://dx.doi.org/10.4049/jimmunol.1501377.